It is being tested in a Phase 2, multicenter, placebo-controlled, double-blind RCT for moderately to severely active UC in 207 participants aged 1875 who have inadequate response to conventional, biologic, or advanced therapies, with the primary outcome measuring clinical remission at week 12 using mMS, currently recruiting with estimated completion in August 2027 (NCT06254950)
You definitely know when youre full, you almost hit a wall and stop eating
Is BACE1 a suitable therapeutic target for the treatment of Alzheimers disease
Safety & Medical Supervision at Our GLP 1 Clinic in North Dallas, TX Are you interested in learning more about how GLP-1 microdosing could help you get and stay healthier
Diabetes medications have well-established coverage frameworks across commercial and government payers
Tuy nhin collagen trong thc t cn c nhiu vai tr quan trng hn v l thnh phn ca nhiu cu trc trong c th